Despite treatment with statins, many patients with elevated cholesterol levels will still develop cardiovascular disease. It is apparent that not only cholesterol but also the immune system plays an important role in the development of atherosclerosis. Researchers now provide a novel potential explanation for this residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023